PAK4 and non-small cell lung carcinoma: Western blot and qPCR were conducted to identify the correlation between the expression of PAK4 and chemoresistance in NSCLC, using 20 primary cisplatin-sensitive and 20 matched cisplatin-resistant NSCLC tissues as samples (after chemotherapy, the patients became cisplatin-resistant).